Skip to Main Content
Back to News

Lobbying Update: $260,000 of GUARDANT HEALTH lobbying was just disclosed

None

$260,000 of GUARDANT HEALTH lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Monitor issues related to cancer diagnostic testing and medicare coverage of cancer screening tests. Support increased funding and reforms for the USPSTF to initiate early action reviews. Monitor issues related to advanced diagnostics and precision cancer care and track proposals to develop novel screening technologies. Support parts of the end of year continuing resolution and oppose other parts."

You can find more data on corporate lobbying on Quiver Quantitative.

GH Insider Trading Activity

GH insiders have traded $GH stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $GH stock by insiders over the last 6 months:

  • MUSA TARIQ has traded it 2 times. They made 0 purchases and 2 sales, selling 2,436 shares.
  • MEGHAN V. JOYCE has traded it 2 times. They made 0 purchases and 2 sales, selling 2,996 shares.
  • KUMUD KALIA (Chief Information Officer) sold 7,000 shares.
  • IAN T CLARK has traded it 2 times. They made 0 purchases and 2 sales, selling 8,318 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GH Hedge Fund Activity

We have seen 133 institutional investors add shares of GH stock to their portfolio, and 126 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles